Trial title not recorded
LDL Hyperlipoproteinemia
Enrolment: 36 · Results not recorded
Nutraceutical
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
LDL Hyperlipoproteinemia
Enrolment: 36 · Results not recorded
Advanced or Metastatic Colorectal Cancer
Enrolment: 33 · Results not recorded
Coronary Artery Disease
Enrolment: 30 · Results not recorded
Biological Availability
Enrolment: 13 · Results not recorded
Healthy
Enrolment: 20 · Results not recorded
Hypertension in Pregnancy
Enrolment: 52 · Results not recorded
Type 2 Diabetes Mellitus · Obesity
Enrolment: 60 · Results not recorded
Postprandial Responses
Enrolment: 10 · Results not recorded
1 studies reported at therapy level; 1 evidence entries itemised.
Model: Caerulein-induced acute pancreatitis with associated colonic injury; caerulein 50 microgram/kg intraperitoneally hourly for 10 h
Hydroxytyrosol 5 mg/kg reduced serum amylase and lipase, serum and tissue IL-1 beta, IL-6 and TNF-alpha and MCP1/CCL2, lowered histological damage scores in pancreas and colon, reduced mast cell recruitment, intrapancreatic trypsin activity, pancreatic oedema and myeloperoxidase activity, and reduc…
Extraction: extract · Supplied extraction confidence: 0.85. Machine-extracted fields require source verification.